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Abstract 
Porcine circovirus type 2 (PCV2) is a ubiquitous pathogen in the swine industry worldwide. Previous studies have 
shown that PCV2 infection induces host cell apoptosis through up-regulation of p53. To further identify the regula-
tory roles of p53 signaling in the process of PCV2 infection, we established p53 gene knockout PK15 cell lines using 
the genomic editor tool CRISPR/Cas9, and further investigated the roles of p53 in modulating the cell cycle and viral 
replication in this study. The results show that PCV2 infection induced obvious S phase accumulation in wild-type 
PK15 cells and a compromised S phase accumulation in the p53 gene mutation cells (813PK15p53m/m), but did not 
induce obvious S phase accumulation in the p53 gene knockout cells (148PK15p53−/−) compared with the respec-
tive mock infection. PCV2 infection activated p53 signaling, up-regulated the expression of p21, Cyclin E, and down-
regulated Cyclin A, CDK2. In p53 deficient cells, however, PCV2-induced changes in Cyclin A, CDK2, and Cyclin E were 
efficiently reversed to the basal levels. Detection of PCV2 replication showed decreased viral ORF1 genomic DNA in 
p53 deficient cells (148PK15p533−/−) and p53 mutated cells (813PK15p53m/m) compared with p53 wild-type cells after 
different synchronization treatment. Furthermore, PCV2 viral genomic DNA and Cap protein levels were higher in the 
cells released from S phase synchronized cells than in the cells released from the G0/G1 phase or G2/M phase-syn-
chronized, or asynchronous cells after 18 h post-infection. Taken together, this study demonstrates that PCV2 infection 
induces S phase accumulation to favor viral replication in host cells through activation of the p53 pathway.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
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Introduction
PCV2, belonging to the family Circoviridae, is the main 
pathogen to cause porcine circovirus associated diseases 
(PCVAD) [1], posing a huge threat for world pig hus-
bandry [2]. As a tiny DNA virus, PCV2 infection requires 
host cells to provide necessary resources for replication 
themselves, thus disturbing a variety of cell signaling 
pathways to modulate the host cell cycle, proliferation, 
survival and death to facilitate their infection and repli-
cation [3, 4]. Among the signaling pathways, p53 signal-
ing is essential for control of quiescent cell entry into the 
cell cycle, and regulating cellular DNA replication [5]. 
However, the roles of p53 signaling in modulating cell 
cycle and PCV2 replication has not been defined up to 
date.
Numbers of studies have broadened our understand-
ing of the roles of p53 signaling in the process of different 
virus infection and replication. For instance, Kaposi’s sar-
coma herpesvirus (KSHV) activates host p53 signal and 
induces G2 phase arrest to promote the onset of virus 
replication [6]. Prototype foamy virus (PFV) promotes 
p53 level increase by knockdown of Pirh2 to contrib-
ute to the latency of PFV infection [7]. Herpes simplex 
virus type 2 infection can phosphorylate p53 protein to 
induce the G0/G1 phase arrest [8]. PRRSV manipulates 
the host factors mdm2 and p53 via its Nsp1α to increase 
viral replication at the early stage of infection [9]. Indeed, 
previous studies have shown that PCV2 ORF3 protein 
specifically interacts with porcine ubiquitin E3 ligase 
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Pirh2 to promote p53 accumulation [10], playing an 
important role in PCV2 pathogenesis [11], which indi-
cates the key role of p53 in the interaction of PCV2 and 
the host. However, in-depth study of the roles of p53 
signaling in the process of PCV2 was limited due to lack-
ing of p53 deficient cell line in porcines.
In this study, with the help of the CRISPR/Cas9 system, 
we constructed p53 deficient and mutant porcine cell 
lines, and further detected and compared the difference 
of cell cycle profiles and viral replication between the 
p53 wild-type, p53 deficient and p53 mutant porcine cell 
lines. This study allows us to deeply explore and confirm 




Porcine kidney 15 (PK15) cells purchased from ATCC 
(CCL-33) were cultured in Dulbecco’s Modified Eagle’s 
Medium (Gibco BRL, Gaithersburg, MD, USA) supple-
mented with 10% heat-inactivated fetal bovine serum 
(Thermo Scientific HyClone, Beijing, China), and incu-
bated at 37  °C in a 5% CO2 atmosphere incubator. The 
PCV2 strains (GenBank No. EU366323) used in this 
study were isolated and purified previously by our team 
and stocked in our laboratory, the UV-inactivation was 
performed by UV radiation of the virus for 45 min in the 
hood. The anti-PCV2 Cap primary antibodies were pro-
duced by our team [12, 13]. The primary monoclonal rab-
bit antibodies of p53, p21 and anti-BrdU were purchased 
from Cell Signaling (Cell Signaling Technology, Danvers, 
MA, USA). CDK2, Cyclin A and Cyclin E antibodies 
were purchased from Santa Cruz Biotechnology (Santa 
Cruz, California, CA, USA). The monoclonal antibody 
of β-actin was purchased from sigma (Sigma-Aldrich, 
St. Louis, MO, USA). The FITC goat anti-mouse IgG was 
purchased from BD Biosciences (BD, San Jose, CA, USA).
Cell cycle analysis
The ratio of cells in each phase of the cell cycle was deter-
mined by DNA content using propidium iodide (PI) 
staining followed by flow cytometric analysis. The cells 
plated at a density of 1  ×  106 cells/flask were treated 
with the indicated Multiplicity of infection (MOI) of 
PCV2 for the indicated times as described in the figure 
legends. The cells were trypsinized, washed twice with 
PBS, and fixed with 70% ice-cold ethanol at −20 °C over-
night. Fixed cells were washed with cold PBS and resus-
pended with PI staining solution containing 50  mg/mL 
PI (Sigma-Aldrich), 100  mg/mL RNase A (TIANGEN 
Biotech, Beijing, China), and incubated in the dark for 
30 min. The samples were analyzed using a flow cytom-
eter (Accuri™ C6, BD Biosciences, San Diego, CA, USA).
CRISPR/cas9 KO cell
Targeting sites in the p53 gene were selected using the 
CRISPR program (Genome Engineering. Broad Institute 
Cambridge, MA, USA) Oligonucleotide pairs for the target 
sequences were annealed and the resulting fragments were 
then cloned into the BsmB I sites of lentiCRISPRv2 plasmid 
(Addgene), and co-transfected into HEK293T cells with the 
packaging plasmids psPAX2 (AddGene 12260) to generate 
the lentivirus. 72 h after the transfection, the supernatant 
was collected after three cycles of frozen-thawed. Titers of 
the obtained lentivirus expressing the target sequences were 
determined by qPCR. Finally, the CRISPR/Cas9 mediated 
P53 knockout cells were selected from lentivirus infected 
PK15 cell lines that were cultured in puromycin (500  ng/
mL) DMEM medium for at least 14 days. Genomic DNA 
sequence from PK15 cells was determined using primers: 
148-F: 5′-GACTCCTGTTGTTCCCATCCA-3′; 148-R: 
5′-AGGGAGCCAGCAGTCAAATG-3′; 813-F: 5′-GGGA 
CGGAACAGCTTTGAGGT-3′; 813-R: 5′-CTGTTGGCA 
AATGCCCCAAA-3′.
Cell synchronization
Cells synchronized in G1/G0 phase were obtained by 
serum starvation. PK-15 cells were cultured in serum-
free medium for 24 h or 48 h, and then cells were washed 
with PBS and plated in fresh media to start PCV2 incuba-
tion for 1 h and cultured in 2% FBS DMEM medium for 
18 or 24 h for later analysis. Double thymidine block was 
used for early S phase synchronization. The cells were 
treated for 12 h with 2 mM thymidine, after which cells 
were washed and released into fresh media with MOI = 1 
PCV2 virus then incubated for 1  h, and cultured in 2% 
FBS DMEM medium for 18 h. The cells were treated with 
100 ng/mL nocodazole for 16 h until arrest at the G2/M 
phase, then the cells were released by washing with PBS 
and plated in fresh media to start PCV2 incubation for 
1 h and culture in 2% FBS DMEM medium for 18 h for 
later analysis.
Detection of virus replication
The cells were seeded in culture plates at a density of 
1 ×  106 cells/well, and cultured to reach approximately 
60–70% confluence. PCV2 strains were used to infect the 
cells at a multiplicity of infection of 1. Viral ORF1 frag-
ments were determined in each of the PK15 cell lines 
using primer PCV-F: 5′-AGTACCGGGAGTGGTAGG 
AG-3′; PCV-R: 5′-GTTGAATTCTGGCCCTGCTC-3′. 
The supernatant and the attached cells were collected 
together to extract the DNA.
BrdU incorporation assay
For labeling of S-phase cells, BrdU was added in mid-
log phase cells at a final concentration of 10  µM and 
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incubated for 1 h at 37 °C. The cells were harvested and 
washed with PBS + 1% BSA. The cells were further resus-
pended and fixed overnight in chilled 70% ethanol at a cell 
density of 2 × 106 cells/mL at 4 °C. Further, ethanol was 
removed and the cells were incubated in 2 N HCL+ 0.5% 
Triton X-100 solution for 30 min at RT followed by wash-
ing in 0.1 M Sodium tetraborate solution for 2 min. Then 
the cells were resuspended in PBS/0.5% Tween-20 + 1% 
BSA and incubated with anti-BrdU antibody for 1  h at 
RT. The cells were washed again with the same buffer and 
incubated in PBS/0.5% Tween-20 +  1% BSA with FITC 
goat antimouse antibody for 0.5  h at RT. Then the cells 
were washed and resuspended in RNase + PI at RT for 
0.5 h min and finally centrifuged. The cells were collected 
for flow cytometer analysis.
Western blot
The protein expression was measured by western blot as 
described previously [14]. Briefly, PK15 cells were cul-
tured in a flask, infection was as indicated at an MOI of 
PCV2 virus and harvested at an 18 h interval as described 
above. Whole-cell protein extract was prepared as 
described above. The protein extract from each group 
was loaded to 12% SDS-PAGE, and transferred to PVDF 
membranes. After blocking for 1 h at room temperature, 
the membranes were incubated with primary antibody 
at 4  °C overnight. After being incubated for 1.5  h with 
HRP-conjugated IgG second monoclonal antibody at 
room temperature, the membranes were immersed in an 
ECL reagent (Pierce, Rorkford, IL, USA) and visualized in 
X-ray films. The optical density of each band was quanti-
fied using ImageJ analysis software (NIH, NY, USA) with 
β-actin as an internal control.
Statistical analyses
All data were presented as “mean ±  SEM” in triplicate, 
and analyzed with the Student’s t test using SPSS 17.0 
software (SPSS Inc., Chicago, IL, USA). Differences with 
the controls were considered significant when p < 0.05.
Results
PCV2‑infected cells accumulated at the S phase of the cell 
cycle
Interference of cell cycle progression is a common 
response for many virus infections [15]. In order to inves-
tigate the influence of PCV2 infection on host cell cycle 
progression, PCV2 infected asynchronously PK15 cells 
for different times at different MOI indicated, and cell 
cycle progression was analyzed by flow cytometry. The S 
phase accumulation was observed at 12 h post-infection 
(pi), and further increased at 24 and 48  h pi in PCV2-
infected cells (Figure 1A). At 24 h pi, the cell population 
of S phase in PCV2-infected cells was close to 1.5-fold 
higher than that in mock-infected cells. At 48  h pi, the 
proportion of cells in the S phase remained at higher lev-
els in PCV2-infected cells compared to mock infection 
cells, and the S phase cell accumulation reached a rela-
tively stationary level in different MOI of PCV2 infected 
cells. These results indicate that PCV2 infection inter-
feres with the cell cycle progression by delaying (prolong-
ing) the S phase of the cell cycle.
We further addressed serum-starved quiescence cells 
to monitor the quantification of DNA cycle fractions 
upon PCV2 infection. PK15 cells were serum-starved 
for 24 h followed by PCV2 infection. S phase cell popu-
lations increased by 1.32-, 1.46- and 1.31-fold at 12, 24 
and 48  h pi, respectively, in PCV2-infected cells, com-
pared to that in mock infection cells, which was accom-
panied by a concomitant decrease in the G0/G1 or G2/M 
phase cell populations (Figure 1B), indicating that PCV2 
blocked the cell cycle at the S phase. At 48 h pi, the G2/M 
population of the cell was markedly reduced, suggesting 
the complete blockage of the S-G2 transition in PCV2-
infected cells. Meanwhile, viral ORF1 genomic DNA in 
PCV2-infected cells (MOI = 1) was monitored by qPCR 
from the asynchronic and synchronic of infection cells, 
the total ORF1 genomic DNA were amplified from 12 h, 
and significantly increased at 24 and 48 h pi (Figure 1C). 
To determine whether PCV2-induced S phase accumu-
lation was dependent on the viral replication, 1 MOI of 
UV-inactivated PCV2 was inoculated with synchronized 
PK-15 for 24 h to measure the cell cycle profiles by flow 
cytometry. The results show that there was no significant 
difference for cell cycle distribution between the UV-
inactivated PCV2 group and the mock infection group 
(Figure  1D), suggesting that UV-inactive PCV2 virus 
did not alter cell cycle distribution, and viral replication 
was required for induction of cell cycle arrest in PCV2-
infected cells. These results indicate that PCV2 infec-
tion induces numerous host cells to accumulate in the S 
phase, which might be beneficial for virus replication.
Loss of p53 impairs PCV2 induced S phase accumulation 
and viral propagation
In order to determine the roles of p53 in PCV2 infection 
and S phase accumulation, the p53 gene was mutated 
using the CRISPR/Cas9 system to address its role in 
PCV2–cell interaction. gRNA for mutagenesis of the 
p53 gene were designed according to the CRISPR/cas9 
program. Target sites were selected from sequences 
with low homologies to other genome sites to avoid 
off-target mutagenesis. gRNA148 targeted around the 
N-terminal domain of p53 which is related to the trans-
activation subdomain and proline-rich fragment; gRNA 
813 targeted the middle area of the central core region, 
which encodes the DNA binding domain necessary for 
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protein–DNA interaction (Figure 2A). Puromycin-resist-
ant PK15 cells were selected at 500  ng/mL and further 
amplified, then subsequently examined by western blot. 
The 148-gRNA generated clone showed complete elimi-
nation of the p53 protein, while the 813-gRNA generated 
clone slightly decreased expression as presented (Fig-
ure  2B). To further check the genomic changes of the 
two positive clones, we designed two pairs of primers 
flanking three gRNA target sites to perform PCR ampli-
fication and sequencing. The 148-gRNA driven cell line 
Figure 1 Cell cycle distribution of PCV2-infected PK15 cells. A Flow cytometry analysis of cell cycle subversion in mock-infected or PCV2-
infected PK15 asynchronously growing cells. Cells were fixed in ethanol at 12, 24, and 48 h post-infection (pi) with 0.5 and 1 MOI of PCV2, DNA was 
stained with propidium iodide and applied to flow cytometry. B Flow cytometric analysis of cell cycle profiles in serum-starved PK15 cells with 
mock or 1 MOI of PCV2 infection. Cells were fixed in ethanol at the indicated time and stained with PI. The percentages of each cell cycle phase 
(G0/G1, G2, S) were output and analyzed by ModFit LT software in the right panel. C qPCR determined the level of PCV2 ORF1 genomic DNA at 
the indicated infection time in PCV2-infected asynchronic and G0/G1 synchronic cells. D Cell cycle profiles were measured after 1 MOI PCV2 or 
UV-inactivated PCV2 infected cells for 24 h. The data are mean ± SEM of three independent experiments. *p < 0.05, versus mock infected cells at the 
same time points (A, B, D). #p < 0.05, ##p < 0.01 versus 6 h pi, in the same infected cells (C).
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(148PK15P53−/−) genomic sequencing displayed a single 
nucleotide insertion leading to the serine 47 site muta-
tion to alanine and introduced an early stop codon, while 
the 813-gRNA driven cell line (813PK15P53m/m) displayed 
mutations at serine 271 and glycine 272 sites into argi-
nine (Figure 2C).
Next, the p53 knockout PK15 cells (148PK15P53−/−) 
and p53 mutated PK15 cells (813PK15P53m/m), as well 
as the wild-type PK15 cells (WT), were infected with 1 
MOI of PCV2 for 24  h, then flow cytometry analyzed 
cell cycle distribution. The results show that compared 
with PCV2-infected WT cells, the percentage of S phase 
Figure 2 Construction of p53 knock-out PK15 cells using CRISPR/Cas9 genome editing system. A Schematic chromatogram representa-
tion of sgRNA targeting at the p53 genomic region. PAM sequences are underlined and highlighted in green. sgRNA targeting sites are highlighted 
in red. The red arrow indicates a putative cleavage site. The lower panel represents the functional domain of the p53 gene. The selected DNA oligos 
for the gRNA were annealed and cloned into the lentivirus vector for the CRISPR/Cas9 system. B Western blot analysis of the p53 expression after 
CRISPR/Cas9 lentivirus system targeting p53 locus infected PK15. The cells infected with lentiviruses containing gRNA-148 (148), gRNA-813 (813) 
or control gRNA (vector) were selected by puromycin, then puromycin-resistant cells and wild-type PK15 cells (WT) were analyzed using western 
blot. The data are mean ± SEM of three independent experiments. *p < 0.05, **p < 0.01 versus WT cells. C Sequencing of p53 locus amplified from 
the 148-gRNA (p53148) and gRNA-813 (p53813) generated cell clone. Red arrows indicate insertions or mutations. PAM sequences are highlighted in 
green. Red dashes indicate deleted bases or amino acids. Red characters indicate inserted base or mutated amino acids.
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cells significantly decreased in both PCV2-infected 
148PK15P53−/− cell and PCV2-infected 813PK15P53m/m 
cells (Figure  3A). Consistently, PCV2 infection did not 
induce S phase accumulation in p53 knockout PK15 
cells (148PK15P53−/−) compared with mock infection, 
while PCV2 infection slightly increased the percent-
ages of S phase cells in 813PK15P53m/m cells. To further 
determine the exact effects of p53 deficiency and muta-
tion on the cell cycle distribution of PCV2-infected cells, 
we detected and compared the extent of S phase DNA 
synthesis between the PCV2-infected group and mock-
infected group in wild-type PK15 cells, p53 gene knock-
out cells (148PK15p53−/−) and p53 gene mutation cells 
(813PK15p53m/m) by BrdU incorporation assay, which 
showed similar results as Figure  3A. Following PCV2 
infection, the extent of S phase DNA synthesis increased 
from 33.0 to 51.3% in wild type cells, whereas the p53 
knockout cells exhibited a relatively stabilized DNA syn-
thesis rate after PCV2 infection even though the p53 
knockout cell has an initial relatively tight cluster cell 
cycle phase distribution and DNA synthesis rate (Fig-
ure  3B). At 6  h pi, 148PK15P53−/− cells, 813PK15P53m/m 
cells and WT cells did not have significantly different lev-
els of viral DNA. At 24 and 48  h pi, the 148PK15P53−/− 
cells exhibited lower viral level than WT cells, while 
813PK15P53m/m cells just showed a slight reduction com-
pared with WT cells in viral level (Figure  3C). These 
results demonstrate that p53 plays a pivotal role in PCV2-
induced S phase cell accumulation and viral replication.
p53 mediates up‑regulation of p21 and Cyclin E 
and down‑regulation of Cyclin A, CDK 2 in PCV2‑infected 
cells
To elucidate the potential mechanisms involved when 
PCV2 infection induces S phase accumulation and p53 
regulates cell cycle progression in infection cells, we 
examined the Cyclin and CDK proteins that are involved 
in the regulation of cell cycle transition. As shown in Fig-
ure 4A, a marked increase (about 2.3-fold) in p53 protein 
level was observed in WT PK15 cells 12  h after PCV2 
infection, followed by p21 and Cyclin E up-regulation, 
whereas Cyclin A and CDK2 levels were significantly 
decreased in PCV2-infected cells at 24 and 48 h pi. The 
up-regulated expression level of Cyclin E may contrib-
ute to the cell cycle progression from G0/G1 to S phase. 
These results indicate that the increase of p53, p21 and 
Cyclin E together with the decrease of Cyclin A and 
CDK2, might be involved in the induction of the S phase 
accumulation in PCV2 infection cells.
However, in the p53 knockout PK15 cells 
(148PK15P53−/−), p53 could not be detected, and p21 also 
could not be detected at 18 and 36 h after PCV2 infec-
tion. In accordance with these changes, the p53 knockout 
cells exhibited relatively higher levels of Cyclin A and 
CDK2 and relatively lower levels of Cyclin E compared 
with wild-type cells at 18 and 36 h pi (Figure 4B). Mean-
while, p53 mutated PK15 cells (813PK15P53m/m) showed 
relatively lower levels of p53, Cyclin E and relatively 
higher levels of Cyclin A when compared with WT cells, 
but relatively lower levels of Cyclin A and CDK2 when 
compared with 148PK15P53−/− cells at 18 and 36  h pi. 
These results suggest that PCV2 induced S phase accu-
mulation through p53 mediated up-regulation of p21, 
Cyclin E and down-regulation of Cyclin A, CDK 2 pro-
teins in PK15 cells.
S phase accumulation promotes PCV2 replication
To investigate the effects of S phase accumulation on 
PCV2 replication, we synchronized the cells at G0/G1 
phase, G2/M phase and G1/S phase, and the cells were 
either mock infected or PCV2 infected. Then we analyzed 
the cell cycle profile as well as the PCV2 genomic DNA 
level and Cap protein level. The results show that using 
serum deprivation treatments for 48 h, over 80% of WT 
PK-15 and 75% of 148PK15P53−/− cells were synchronized 
at the G0/G1 phase (Figure 5A). Using double-thymidine 
treatment, approximately 75% of WT cells and 70% of 
148PK15P53−/− cells were synchronized at the G1/S phase 
border (Figure  5B). Using nocodazole treatments, over 
75% of WT PK-15 cells and 70% of 148PK15P53−/− cells 
were synchronized at the G2/M phase (Figure  5C). In 
the WT cells released from the G0/G1 phase synchro-
nized cells, the proportion of S phase cells increased 
about 23% in PCV2-infected cells compared to that in 
mock-infected cells at 18  h pi (Figure  5A). In the WT 
cells released from the G1/S synchronized cells, the cell 
population at the S phase increased about 38% in PCV2-
infected cells compared to that in mock-infected cells at 
18  h pi (Figure  5B). In the WT cells released from the 
G2/M phase synchronized cells, the cell population at 
the S phase increased about 40% in PCV2-infected cells 
compared to that in mock-infected cells at 18 h pi (Fig-
ure  5C). However, in 148PK15P53−/− cells released from 
the G0/G1 phase, G1/S phase or G2/M phase synchro-
nized cells, the cell population at the S phase in PCV2-
infected cells decreased compared with that in wild-type 
cells or similar to that found in mock-infected cells at 18 
h pi (Figure 5A–C). In 813PK15P53m/m cells released from 
the G0/G1 phase, G1/S phase or G2/M phase synchro-
nized cells, the cell populations at the S phase were also 
increased in PCV2-infected cells compared to those in 
mock-infected cells at 18 h pi, but which were also lower 
than those in PCV2-infected WT cells (Figure 5A–C).
Real-time PCR analysis of the genomic DNA of PCV2 
shows that the replication levels of ORF1 DNA were 
higher in the WT cells released from G1/S-synchronized 
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cells than those in the WT cells released from G0/G1 
phase or G2/M phase synchronized, or asynchronous 
WT cells (Figure 5D). In addition, the levels of the PCV2 
Cap protein also were higher in the WT cells released 
from G1/S-synchronized cells than those in the WT cells 
released from G0/G1 phase or G2/M phase synchro-
nized or asynchronous cells (Figure  5E). However, the 
viral DNA levels and Cap protein levels were lower in the 
Figure 3 p53 mediates PCV2-induced S phase accumulation and promotes viral multiplication. A Flow cytometry analysis of cell cycle 
subversion in serum-starved WT PK15, 148PK15P53−/−, and 813PK15P53m/m cells upon PCV2 infection (MOI = 1). Cells were fixed in ethanol at 24 h pi, 
DNA was stained with propidium iodide and applied to flow cytometry. The percentages of each cell cycle phase (G0/G1, G2, S) were output and 
analyzed by ModFit LT software in the right panel. B Quantitative analysis of S-phase entry (percentage of BrdU-positive cells) exposed to the 1 MOI 
PCV2 for 12 h and successively cultured in the BrdU for 1 h. C Absolute quantification of PCV2 replication in WT, 148PK15P53−/−, and 813PK15P53m/m 
cells. 1 MOI of PCV2-infected asynchronously growing WT, 148PK15P53−/−, or 813PK15P53m/m, and viral ORF1 DNA were determined by the combina-
tion of the supernatant fluids and cytoplasmic extraction at 12, 24, 48 h pi. The data are mean ± SEM of three independent experiments. *p < 0.05 
versus mock infection in the same kinds of cells. #p < 0.05 versus PCV2-infected WT cells at same time point.
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148PK15P53−/− and 813PK15P53m/m cells released from the 
G1/S phase synchronized cells than those in the WT cells 
released from the G1/S phase synchronized cells (Fig-
ure 5D and F). These results suggest that PCV2 induction 
of S phase accumulation via p53 signaling might be benefi-
cial for virus replication.
Discussion
Viruses evolve complex strategies to override cell cycle 
checkpoints forcing host cells into specific phases to sup-
port viral replication. Some viruses interfere with the p53 
surveillance pathways to promote replication [16, 17], other 
viruses exhibited a p53-independent way for its replication 
[18, 19]. In this study, we focused on whether the p53 sign-
aling pathway contributes to PCV2 induced cell cycle pro-
gression and virus replication. The results show that PCV2 
infection activated the p53 signaling to up-regulate p21 
and Cyclin E while down-regulating Cyclin A and CDK2, 
forcing the infected cells to stay in the replicative S phase. 
The roles of p53 in PCV2 replication were further tested by 
infection of p53 knockout and p53 mutant cells, in which 
the progression of the cell cycle was less effected by PCV2 
and the replication of virus appears a relative lower level.
In this study, the first question we answered is whether 
PCV2 overrides cell cycle checkpoints for its benefits. In 
both asynchronic and synchronic cells, PCV2 induced 
cell cycle arrest at the S phase and promoted both PCV2 
capsid protein and PCV2 progeny production, whereas 
UV-inactivated PCV2 did not exhibit S-phase accumula-
tion. Besides this, PCV2 genomic DNA and Cap protein 
levels were higher in the WT cells released from G1/S-
synchronized cells than those in the WT cells released 
from G0/G1 phase or G2/M phase synchronized, or 
asynchronous WT cells, suggesting that S phase accumu-
lation might be beneficial for virus replication. Our data 
explain and agree with the previous reports that PCV2 
DNA synthesis dramatically increases in PK15 cells right 
before mitosis [20], while the cell cycle regulator protein 
Cyclin A overexpression suppressed PCV2 replication 
[21]. Thus, we confirmed that PCV2 infection induced 
S-phase accumulation for its multiplication.
The other main question we answered is the roles of 
p53 signaling in modulating cell cycle arrest and PCV2 
replication. The function of p53 in regulating the cell 
cycle progress of PCV2-infected cells was explored by 
comparing p53 wild-type, knockout and mutant cell 
lines. Following PCV2 infection, p53 knockout caused 
significant reduction of DNA synthesis compared with 
the wild-type cell, whereas the p53 knockout cells exhib-
ited a relatively stabilized high DNA synthesis rate 
whether in the presence or absence of PCV2 in the BrdU 
assay. We also observed that PCV2 genomic DNA levels 
and Cap protein levels were lower in the 148PK15P53−/− 
and 813PK15P53m/m cells released from G1/S phase syn-
chronized cells than those in the WT cells released from 
G1/S phase synchronized cells. These results suggest that 
p53 plays a pivotal role in inducing S-phase cell accumu-
lation and viral replication in PCV2-infected cells.
Actually, the role of p53 interplays between the host 
and virus has been extensively studied. Some viruses 
hijack the p53 apoptotic pathway to facilitate virus 
invasion, like Influenza A virus [22], Reovirus [23], and 
Epstein–Barr virus [24] while other virus proteins directly 
interact with p53 effecting both p53 DNA-binding affin-
ity and transcriptional ability, such as Hepatitis C virus 
[25], and Hepatitis B virus [26]. In addition, some viruses 
specifically interrupt the cellular p53–p21 pathway to 
modulate the host cell cycle, blocking cellular DNA 
synthesis in generating viral nucleotide pools, like Res-
piratory syncytial virus [27], Herpes simplex virus type 
2 (HSV-2), and Simian virus 40 (SV40). However, unlike 
HSV-2, which increases p21 protein levels by phospho-
rylation of the p53 protein at Ser20 [8], SV40 induced 
Figure 4 p53 modulates cell cycle regulators in the process of 
PCV2 infection. A Western blot analysis of the levels of cell cycle 
proteins in PCV2-infected PK15 cells. Cells were collected from Mock-
infected or PCV2-infected (MOI = 1) at the indicated time points and 
processed for western blot analysis. B Cell cycle proteins change in 
WT, 148PK15P53−/−, and 813PK15P53m/m cells with mock or PCV2 infec-
tion. Cells were collected at the indicated time points and subjected 
to western blot analysis as described in “Materials and methods” sec-
tion. Data represent three independent experiments.
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p53 phosphorylation is accompanied by Ser15 [28], as 
SV40 activating the ATR-Delta p53 signaling to main-
tain S phase environment, and to manipulate polymer-
ases [17]. This may explain our data that in the CRISPR/
Cas 9 mediated 148PK15P53−/− cells, PCV2 infection did 
not induce S phase accumulation, resulting in a relative 
lower virus production, while the 813PK15P53m/m cells 
that mutated original S271 and G272 sites of porcine 
p53 into R271 showed a slightly weakened function of 
p53 signaling undergoing PCV2 infection, resulting in a 
slight relative decreased S phase accumulation compared 
with the wild-type cell. Single amino acid mutation of 
p53 exhibited a different function, the human R273 site 
mutation induced a resistance to drug which induced 
apoptosis, while the mouse R270 residue is subject to 
stress-induced modifications [29, 30]. Similarly, in this 
study, the deletion of a single amino acid located at the 
sensitive key site, affected the progression of cell cycle in 
813PK15P53m/m cells. Interestingly, the delta p53 signal-
ing, an alternative p53 isoform deleted from 256 to 322 
Figure 5 S phase accumulation promotes PCV2 replication. A PK15 cells, 148PK15P53−/− cells, or 813PK15P53m/m cells were cultured with-
out serum for 48 h to synchronize at G0/G1 phase, followed by PCV2 (MOI = 1) or mock-infection. At 18 h post-infection, cells were stained with 
propidium iodide and applied to flow cytometry analysis. B Cells were synchronized in G1/S phase by 2 mM double-thymidine block for 12 h to 
release into the S phase. Then the cells were infected with 1 MOI PCV2 for 18 h and applied to flow cytometry analysis. C Cells were synchronized 
in G2/M phase by treatment with 100 ng/mL of nocodazole for 16 h. Then the cells were infected with 1 MOI PCV2 for 18 h and applied to flow 
cytometry analysis. D PCV2 ORF1 DNA levels were determined by qPCR at 18 h after infection (MOI = 1) in the cells. The data are mean ± SEM of 
three independent experiments. **p < 0.01 versus WT cells released from G1/S phase group. #p < 0.05, ##p < 0.01 versus WT cells released from the 
same phase. E Western blot analysis of PCV2 Cap levels in the WT cells released from different synchronization treatments as above. F Western blot 
analysis of PCV2 Cap levels in WT PK15 cells, 148PK15P53−/− cells, or 813PK15P53m/m cells released from G1/S phase synchronized cells. Data represent 
three independent experiments.
Page 10 of 11Xu et al. Vet Res  (2016) 47:120 
amino acid residues, is activated upon the DNA virus 
SV40 infection or when the host cells encounter a single-
strand DNA break, resulting in up-regulation of p21 and 
down-regulation of Cyclin A-CDK2 in S phase [17, 31]. In 
the current study, following PCV2 infection, an increase 
of p21 and a decrease of Cyclin A-CDK2 was observed, 
while in the p53 deficient cells, the level of expression of 
Cyclin A-CDK2 was efficiently altered to the basal level.
The CRISPR/Cas9-mediated gene editing system has 
emerged as a powerful and efficient tool to manipulate 
the genomes of potential targets to understand pathogen-
eses [32, 33]. Taking advantage of this technology allowed 
us to conduct basic research on p53 signaling in porcine 
cell lines. Even though the exact molecular mechanism of 
PCV2 infected cell response to p53 signaling still needs 
to be further studied, our data presented here confirmed 
that PCV2 induced cell cycle accumulates at the S phase 
for its replication, and p53 signaling contributes to this 
modulation process.
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